<DOC>
	<DOCNO>NCT00994136</DOCNO>
	<brief_summary>Long-term central venous access device consider safe administration medication chemotherapy , also use blood sampling . For year catheter lock heparin solution order avoid occlusion . However , scientific evidence support heparin lock device use . Advanced technology needleless cap valved catheter port reservoir confirms trend use 'saline ' lock device . Therefore investigator hypothesize difference proportion occlusion catheter relate bacteremia long-term venous access device lock 'saline ' versus heparin .</brief_summary>
	<brief_title>Safety Catheter Lock With Without Heparin Implanted Central Venous Catheters</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Oncology hematology patient Life expectancy minimum 180 day second femoral longterm central venous access device know allergy heparin ( HIT ) coagulation disorder ( INR &gt; 2 , Blood platelet &gt; 1,000,000/mm3 ) therapeutic intravenous heparin administration</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Catheters , indwell</keyword>
	<keyword>Catheterization , Central Venous</keyword>
	<keyword>Withdrawal occlusion</keyword>
	<keyword>Heparin lock</keyword>
</DOC>